Equities

MANI Inc

MANI Inc

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,786.00
  • Today's Change9.00 / 0.51%
  • Shares traded169.90k
  • 1 Year change-16.33%
  • Beta0.6291
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year MANI Inc grew revenues 16.44% from 24.49bn to 28.51bn while net income improved 5.59% from 5.95bn to 6.29bn.
Gross margin62.77%
Net profit margin22.05%
Operating margin29.27%
Return on assets11.21%
Return on equity12.31%
Return on investment12.09%
More ▼

Cash flow in JPYView more

In 2024, cash reserves at MANI Inc fell by 2.78bn. However, the company earned 7.81bn from its operations for a Cash Flow Margin of 27.39%. In addition the company used 6.64bn on investing activities and also paid 3.70bn in financing cash flows.
Cash flow per share68.78
Price/Cash flow per share28.07
Book value per share531.17
Tangible book value per share517.59
More ▼

Balance sheet in JPYView more

MANI Inc has little financial risk as the capital structure does not rely on leverage.
Current ratio8.17
Quick ratio6.54
Total debt/total equity0.0016
Total debt/total capital0.0016
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 11.43% and 5.56%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)1.42%
Div growth rate (5 year)20.53%
Payout ratio (TTM)25.06%
EPS growth(5 years)0.581
EPS (TTM) vs
TTM 1 year ago
5.56
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.